The risk or severity of adverse effects can be increased when Bortezomib is combined with Carbetocin.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with meclizine.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with Propiverine.


The risk or severity of adverse effects can be increased when biperiden is combined with Metixene.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when levodopa is combined with Difenoxin.


The risk or severity of adverse effects can be increased when mesalamine is combined with halcinonide.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with Salbutamol.


The risk or severity of adverse effects can be increased when minoxidil is combined with Eplerenone.


The risk or severity of adverse effects can be increased when Estrone sulfate is combined with edrophonium.


The risk or severity of adverse effects can be increased when Arotinolol is combined with selegiline.


The risk or severity of adverse effects can be increased when cetirizine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when oxiconazole is combined with simvastatin.


The risk or severity of adverse effects can be increased when Trospium is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when benzphetamine is combined with procarbazine.


The risk or severity of adverse effects can be increased when oxazepam is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when oxazepam is combined with glutethimide.


The risk or severity of adverse effects can be increased when amphotericin b is combined with furosemide.


The risk or severity of adverse effects can be increased when cetirizine is combined with triprolidine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with tizanidine.


The risk or severity of adverse effects can be increased when flumethasone is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when amphotericin b is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when paramethasone is combined with fleroxacin.


The risk or severity of adverse effects can be increased when amphotericin b is combined with phentolamine.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when nitric oxide is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when nitric oxide is combined with acetaminophen.


The risk or severity of adverse effects can be increased when oxaprozin is combined with betamethasone.


The risk or severity of adverse effects can be increased when Ramelteon is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with acebutolol.


The risk or severity of adverse effects can be increased when dipyridamole is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with MELPERONE.


The risk or severity of adverse effects can be increased when ondansetron is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with flecainide.


The risk or severity of adverse effects can be increased when levorphanol is combined with phenytoin.


The risk or severity of adverse effects can be increased when Fospropofol is combined with Flibanserin.


The risk or severity of adverse effects can be increased when lorazepam is combined with nalbuphine.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Eprosartan is combined with leflunomide.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when oxiconazole is combined with nimodipine.


The risk or severity of adverse effects can be increased when nabumetone is combined with azelastine.


The risk or severity of adverse effects can be increased when carbamazepine is combined with nalbuphine.


The risk or severity of adverse effects can be increased when methadone is combined with gabapentin.


The risk or severity of adverse effects can be increased when methadone is combined with Frovatriptan.


The risk or severity of adverse effects can be increased when temazepam is combined with clonazepam.


The risk or severity of adverse effects can be increased when ketorolac is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with ranitidine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with sertraline.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when thiamylal is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when naratriptan is combined with mesoridazine.


The risk or severity of adverse effects can be increased when meperidine is combined with tiapride.


The risk or severity of adverse effects can be increased when METHAMPHETAMINE is combined with procarbazine.


The risk or severity of adverse effects can be increased when thiothixene is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when thiothixene is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when Saxagliptin is combined with Spirapril.


The risk or severity of adverse effects can be increased when Articaine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when diltiazem is combined with methyldopa.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with halcinonide.


The risk or severity of adverse effects can be increased when TRIMETHAPHAN is combined with tubocurarine.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with quetiapine.


The risk or severity of adverse effects can be increased when Saxagliptin is combined with cilazapril.


The risk or severity of adverse effects can be increased when Articaine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when trazodone is combined with efavirenz.


The risk or severity of adverse effects can be increased when primidone is combined with thiamylal.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when furazolidone is combined with OLODATEROL.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Fospropofol.


The risk or severity of adverse effects can be increased when furazolidone is combined with Vilanterol.


The risk or severity of adverse effects can be increased when sulindac is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when Ixabepilone is combined with clozapine.


The risk or severity of adverse effects can be increased when difluprednate is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when mepivacaine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Melatonin is combined with etizolam.


The risk or severity of adverse effects can be increased when Tolcapone is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when Clobetasone is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when Clobetasone is combined with memantine.


The risk or severity of adverse effects can be increased when alprazolam is combined with methocarbamol.


The risk or severity of adverse effects can be increased when rasagiline is combined with buspirone.


The risk or severity of adverse effects can be increased when proparacaine is combined with glutethimide.


The risk or severity of adverse effects can be increased when rasagiline is combined with oxycodone.


The risk or severity of adverse effects can be increased when midazolam is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when CLOCORTOLONE is combined with decamethonium.


The risk or severity of adverse effects can be increased when linezolid is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when trazodone is combined with Tramadol.


The risk or severity of adverse effects can be increased when salicylic acid is combined with salicylamide.


The risk or severity of adverse effects can be increased when perphenazine is combined with prazepam.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with orphenadrine.


The risk or severity of adverse effects can be increased when atenolol is combined with sotalol.


The risk or severity of adverse effects can be increased when thiopental is combined with Iloperidone.


The risk or severity of adverse effects can be increased when cabergoline is combined with Capsaicin.


The risk or severity of adverse effects can be increased when Clofarabine is combined with penbutolol.


The risk or severity of adverse effects can be increased when salicylic acid is combined with diflorasone.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with Pizotifen.


The risk or severity of adverse effects can be increased when thiopental is combined with phenytoin.


The risk or severity of adverse effects can be increased when estrone is combined with enoxacin.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with budesonide.


The risk or severity of adverse effects can be increased when nicergoline is combined with topotecan.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when Masoprocol is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with oxprenolol.


The risk or severity of adverse effects can be increased when quazepam is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with Salsalate.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when quazepam is combined with baclofen.


The risk or severity of adverse effects can be increased when Efonidipine is combined with isoflurane.


The risk or severity of adverse effects can be increased when diflunisal is combined with Apremilast.


The risk or severity of adverse effects can be increased when Efonidipine is combined with tretinoin.


The risk or severity of adverse effects can be increased when dyclonine is combined with brotizolam.


The risk or severity of adverse effects can be increased when nalbuphine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when terconazole is combined with eperisone.


The risk or severity of adverse effects can be increased when Droxicam is combined with alclofenac.


The risk or severity of adverse effects can be increased when lisinopril is combined with indomethacin.


The risk or severity of adverse effects can be increased when nabumetone is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when DESONIDE is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when thiothixene is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when reserpine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when Lurasidone is combined with Etidocaine.


The risk or severity of adverse effects can be increased when triprolidine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when metoclopramide is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with prazepam.


The risk or severity of adverse effects can be increased when quetiapine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Nebivolol.


The risk or severity of adverse effects can be increased when dapsone is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when isradipine is combined with indapamide.


The risk or severity of adverse effects can be increased when Trospium is combined with PIPECURONIUM.


The risk or severity of adverse effects can be increased when quazepam is combined with loratadine.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with formestane.


The risk or severity of adverse effects can be increased when lorazepam is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when Eletriptan is combined with promethazine.


The risk or severity of adverse effects can be increased when linezolid is combined with sumatriptan.


The risk or severity of adverse effects can be increased when rasagiline is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when clonidine is combined with Retigabine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when codeine is combined with protriptyline.


The risk or severity of adverse effects can be increased when quetiapine is combined with butamben.


The risk or severity of adverse effects can be increased when tacrolimus is combined with gemcitabine.


The risk or severity of adverse effects can be increased when tacrolimus is combined with betamethasone.


The risk or severity of adverse effects can be increased when tacrolimus is combined with Epirubicin.


The risk or severity of adverse effects can be increased when tacrolimus is combined with teniposide.


The risk or severity of adverse effects can be increased when hydromorphone is combined with D-mannitol.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with Flibanserin.


The risk or severity of adverse effects can be increased when oxycodone is combined with tetracaine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with scopolamine.


The risk or severity of adverse effects can be increased when ketorolac is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when Carbetocin is combined with dipyridamole.


The risk or severity of adverse effects can be increased when Vilazodone is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when estazolam is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when imipramine is combined with timolol.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when Dehydroepiandrosterone is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when cinnarizine is combined with Rosuvastatin.


The risk or severity of adverse effects can be increased when cilnidipine is combined with trandolapril.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with Levalbuterol.


The risk or severity of adverse effects can be increased when ILOPROST is combined with quetiapine.


The risk or severity of adverse effects can be increased when budesonide is combined with enoxacin.


The risk or severity of adverse effects can be increased when Flupentixol is combined with loratadine.


The risk or severity of adverse effects can be increased when nimesulide is combined with Deferasirox.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with Agomelatine.


The risk or severity of adverse effects can be increased when indomethacin is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when scopolamine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when secobarbital is combined with clonidine.


The risk or severity of adverse effects can be increased when vigabatrin is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when amoxapine is combined with selegiline.


The risk or severity of adverse effects can be increased when methadone is combined with vigabatrin.


The risk or severity of adverse effects can be increased when meprobamate is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with niflumic acid.


The risk or severity of adverse effects can be increased when ipratropium is combined with hyoscyamine.


The risk or severity of adverse effects can be increased when reserpine is combined with quazepam.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with Pipamperone.


The risk or severity of adverse effects can be increased when mesoridazine is combined with dantrolene.


The risk or severity of adverse effects can be increased when fenoldopam is combined with apraclonidine.


The risk or severity of adverse effects can be increased when meprobamate is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when Fospropofol is combined with nefazodone.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with Pramocaine.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when methysergide is combined with sulfanilamide.


The risk or severity of adverse effects can be increased when Fospropofol is combined with doxepin.


The risk or severity of adverse effects can be increased when protriptyline is combined with Salbutamol.


The risk or severity of adverse effects can be increased when amifostine is combined with LEVOSIMENDAN.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with methadone.


The risk or severity of adverse effects can be increased when buspirone is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when loratadine is combined with zonisamide.


The risk or severity of adverse effects can be increased when aspirin is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when Talniflumate is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when orphenadrine is combined with paroxetine.


The risk or severity of adverse effects can be increased when methysergide is combined with doxycycline.


The risk or severity of adverse effects can be increased when rizatriptan is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when rizatriptan is combined with clomipramine.


The risk or severity of adverse effects can be increased when cabergoline is combined with propofol.


The risk or severity of adverse effects can be increased when cabergoline is combined with acetazolamide.


The risk or severity of adverse effects can be increased when secobarbital is combined with Ramelteon.


The risk or severity of adverse effects can be increased when triazolam is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when alclofenac is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when Pirlindole is combined with mianserin.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when oxycodone is combined with isoflurane.


The risk or severity of adverse effects can be increased when oxycodone is combined with prilocaine.


The risk or severity of adverse effects can be increased when Etidocaine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when procarbazine is combined with hydromorphone.


The risk or severity of adverse effects can be increased when butorphanol is combined with thiamylal.


The risk or severity of adverse effects can be increased when oxycodone is combined with ethotoin.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with haloperidol.


The risk or severity of adverse effects can be increased when trapidil is combined with salicylic acid.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with ZILEUTON.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with triflupromazine.


The risk or severity of adverse effects can be increased when imipramine is combined with irbesartan.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with triamcinolone.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with deslanoside.


The risk or severity of adverse effects can be increased when Agomelatine is combined with Etidocaine.


The risk or severity of adverse effects can be increased when diazepam is combined with thiothixene.


The risk or severity of adverse effects can be increased when imipramine is combined with felodipine.


The risk or severity of adverse effects can be increased when thiamylal is combined with clonidine.


The risk or severity of adverse effects can be increased when protriptyline is combined with scopolamine.


The risk or severity of adverse effects can be increased when procarbazine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when azelastine is combined with Tixocortol.


The risk or severity of adverse effects can be increased when fenoldopam is combined with triamterene.


The risk or severity of adverse effects can be increased when lisinopril is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when Elbasvir is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Pramocaine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Propacetamol is combined with fluocinonide.


The risk or severity of adverse effects can be increased when enalapril is combined with Sodium aurothiomalate.


The risk or severity of adverse effects can be increased when felodipine is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when bromocriptine is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with halcinonide.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Fospropofol.


The risk or severity of adverse effects can be increased when Pipamperone is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when Telmisartan is combined with Droxicam.


The risk or severity of adverse effects can be increased when fludrocortisone is combined with edrophonium.


The risk or severity of adverse effects can be increased when secobarbital is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Telmisartan is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when tropicamide is combined with propantheline.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with fludiazepam.


The risk or severity of adverse effects can be increased when secobarbital is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with primidone.


The risk or severity of adverse effects can be increased when valsartan is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when Mometasone is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when Mometasone is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when Pipotiazine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when bromocriptine is combined with methimazole.


The risk or severity of adverse effects can be increased when bromocriptine is combined with irinotecan.


The risk or severity of adverse effects can be increased when clonidine is combined with methyldopa.


The risk or severity of adverse effects can be increased when clidinium is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with Lorcaserin.


The risk or severity of adverse effects can be increased when procyclidine is combined with ANISOTROPINE METHYLBROMIDE.


The risk or severity of adverse effects can be increased when Pemetrexed is combined with clozapine.


The risk or severity of adverse effects can be increased when oxazepam is combined with Lurasidone.


The risk or severity of adverse effects can be increased when midazolam is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Icatibant is combined with medrysone.


The risk or severity of adverse effects can be increased when fosinopril is combined with celecoxib.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when pimozide is combined with Articaine.


The risk or severity of adverse effects can be increased when secobarbital is combined with scopolamine.


The risk or severity of adverse effects can be increased when levorphanol is combined with amobarbital.


The risk or severity of adverse effects can be increased when methylergonovine is combined with sulfisoxazole.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when clozapine is combined with phentolamine.


The risk or severity of adverse effects can be increased when Alogliptin is combined with captopril.


The risk or severity of adverse effects can be increased when haloprogin is combined with nicardipine.


The risk or severity of adverse effects can be increased when Telmisartan is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when chloroquine is combined with mefloquine.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when levorphanol is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when Torasemide is combined with penbutolol.


The risk or severity of adverse effects can be increased when floctafenine is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with medrysone.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when dantrolene is combined with levodopa.


The risk or severity of adverse effects can be increased when sevoflurane is combined with METAXALONE.


The risk or severity of adverse effects can be increased when mepivacaine is combined with tiagabine.


The risk or severity of adverse effects can be increased when mepivacaine is combined with zonisamide.


The risk or severity of adverse effects can be increased when Eletriptan is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when vigabatrin is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with triamcinolone.


The risk or severity of adverse effects can be increased when Droxicam is combined with Mometasone.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with efavirenz.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with meclizine.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when haloprogin is combined with gabapentin.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with Droxicam.


The risk or severity of adverse effects can be increased when UMECLIDINIUM is combined with codeine.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with digitoxin.


The risk or severity of adverse effects can be increased when Phenelzine is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when nitric oxide is combined with indapamide.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with butamben.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with butamben.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with naratriptan.


The risk or severity of adverse effects can be increased when chloroquine is combined with Icatibant.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with quazepam.


The risk or severity of adverse effects can be increased when prazepam is combined with zonisamide.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when proparacaine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when prazepam is combined with tiagabine.


The risk or severity of adverse effects can be increased when zotepine is combined with clemastine.


The risk or severity of adverse effects can be increased when proparacaine is combined with triprolidine.


The risk or severity of adverse effects can be increased when Lacidipine is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when spironolactone is combined with losartan.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when zotepine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when malathion is combined with Carbamylcholine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with dantrolene.


The risk or severity of adverse effects can be increased when Etomidate is combined with benzocaine.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with Iloperidone.


The risk or severity of adverse effects can be increased when midodrine is combined with ritodrine.


The risk or severity of adverse effects can be increased when oxycodone is combined with dyclonine.


The risk or severity of adverse effects can be increased when lisinopril is combined with fenbufen.


The risk or severity of adverse effects can be increased when Butethal is combined with clonazepam.


The risk or severity of adverse effects can be increased when Butethal is combined with promethazine.


The risk or severity of adverse effects can be increased when loxapine is combined with phenytoin.


The risk or severity of adverse effects can be increased when metolazone is combined with indapamide.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with oxprenolol.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when oxycodone is combined with propoxyphene.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when levorphanol is combined with ethotoin.


The risk or severity of adverse effects can be increased when sotalol is combined with bumetanide.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with quazepam.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with prazepam.


The risk or severity of adverse effects can be increased when levorphanol is combined with prilocaine.


The risk or severity of adverse effects can be increased when trandolapril is combined with Masoprocol.


The risk or severity of adverse effects can be increased when levorphanol is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when sotalol is combined with quinapril.


The risk or severity of adverse effects can be increased when cocaine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when baclofen is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when baclofen is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with tiapride.


The risk or severity of adverse effects can be increased when perphenazine is combined with Normethadone.


The risk or severity of adverse effects can be increased when floctafenine is combined with azelastine.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with triflupromazine.


The risk or severity of adverse effects can be increased when FLUOCORTOLONE is combined with donepezil.


The risk or severity of adverse effects can be increased when Demecarium is combined with acetylcholine.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with haloperidol.


The risk or severity of adverse effects can be increased when griseofulvin is combined with diltiazem.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when Conivaptan is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when triazolam is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when triazolam is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when ILOPROST is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when Droxicam is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when Icatibant is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when vigabatrin is combined with Difenoxin.


The risk or severity of adverse effects can be increased when labetalol is combined with Carbamylcholine.


The risk or severity of adverse effects can be increased when methysergide is combined with epinephrine.


The risk or severity of adverse effects can be increased when benazepril is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when thioridazine is combined with zaleplon.


The risk or severity of adverse effects can be increased when lidocaine is combined with HEROIN.


The risk or severity of adverse effects can be increased when thioridazine is combined with mepivacaine.


The risk or severity of adverse effects can be increased when thioridazine is combined with Telmisartan.


The risk or severity of adverse effects can be increased when METAXALONE is combined with levodopa.


The risk or severity of adverse effects can be increased when thioridazine is combined with methyldopa.


The risk or severity of adverse effects can be increased when Tavaborole is combined with barnidipine.


The risk or severity of adverse effects can be increased when phentolamine is combined with thioridazine.


The risk or severity of adverse effects can be increased when zaleplon is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when clomipramine is combined with irbesartan.


The risk or severity of adverse effects can be increased when ketamine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when ketamine is combined with triprolidine.


The risk or severity of adverse effects can be increased when clomipramine is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when clomipramine is combined with felodipine.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with methazolamide.


The risk or severity of adverse effects can be increased when Fondaparinux is combined with Nintedanib.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when Normethadone is combined with selegiline.


The risk or severity of adverse effects can be increased when nalbuphine is combined with pimozide.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with nitrazepam.


The risk or severity of adverse effects can be increased when zaleplon is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when meperidine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with Riociguat.


The risk or severity of adverse effects can be increased when haloprogin is combined with nilvadipine.


The risk or severity of adverse effects can be increased when oxycodone is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when ibuprofen is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with MELPERONE.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with zotepine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Mersalyl.


The risk or severity of adverse effects can be increased when chlormezanone is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when sulpiride is combined with triprolidine.


The risk or severity of adverse effects can be increased when estazolam is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when diflorasone is combined with ROSOXACIN.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when betamethasone is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when ramipril is combined with diclofenac.


The risk or severity of adverse effects can be increased when isoflurane is combined with clonazepam.


The risk or severity of adverse effects can be increased when ramipril is combined with enalapril.


The risk or severity of adverse effects can be increased when propofol is combined with Clevidipine.


The risk or severity of adverse effects can be increased when isoflurane is combined with Melatonin.


The risk or severity of adverse effects can be increased when celiprolol is combined with Carbamylcholine.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with mecamylamine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with enalapril.


The risk or severity of adverse effects can be increased when bromocriptine is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when moclobemide is combined with domperidone.


The risk or severity of adverse effects can be increased when codeine is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when codeine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when codeine is combined with prochlorperazine.


The risk or severity of adverse effects can be increased when Clofarabine is combined with leflunomide.


The risk or severity of adverse effects can be increased when clozapine is combined with Articaine.


The risk or severity of adverse effects can be increased when indomethacin is combined with amcinonide.


The risk or severity of adverse effects can be increased when nitric oxide is combined with nadolol.


The risk or severity of adverse effects can be increased when thiopental is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when quinapril is combined with felodipine.


The risk or severity of adverse effects can be increased when indomethacin is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when quinapril is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when quinapril is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with mycophenolate mofetil.


The risk or severity of adverse effects can be increased when glutethimide is combined with zonisamide.


The risk or severity of adverse effects can be increased when Butoconazole is combined with nitrendipine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when glutethimide is combined with tiagabine.


The risk or severity of adverse effects can be increased when maprotiline is combined with lithium ion.


The risk or severity of adverse effects can be increased when azelastine is combined with salicylic acid.


The risk or severity of adverse effects can be increased when Desloratadine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with quetiapine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with clonazepam.


The risk or severity of adverse effects can be increased when flurazepam is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with Melatonin.


The risk or severity of adverse effects can be increased when etodolac is combined with haloperidol.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when lidocaine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when Halazepam is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when clidinium is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when methazolamide is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when propoxyphene is combined with acetazolamide.


The risk or severity of adverse effects can be increased when Butethal is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when Butethal is combined with flunarizine.


The risk or severity of adverse effects can be increased when pergolide is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when Butethal is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when CLOBETASOL PROPIONATE is combined with edrophonium.


The risk or severity of adverse effects can be increased when azelastine is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with penbutolol.


The risk or severity of adverse effects can be increased when halothane is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when halothane is combined with doxazosin.


The risk or severity of adverse effects can be increased when halothane is combined with ethosuximide.


The risk or severity of adverse effects can be increased when quetiapine is combined with dantrolene.


The risk or severity of adverse effects can be increased when ipratropium is combined with pirenzepine.


The risk or severity of adverse effects can be increased when fluoxetine is combined with nifedipine.


The risk or severity of adverse effects can be increased when halothane is combined with labetalol.


The risk or severity of adverse effects can be increased when CLOCORTOLONE is combined with mefloquine.


The risk or severity of adverse effects can be increased when scopolamine is combined with maprotiline.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Conivaptan.


The risk or severity of adverse effects can be increased when Icatibant is combined with Deferasirox.


The risk or severity of adverse effects can be increased when clomipramine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when zaleplon is combined with Asenapine.


The risk or severity of adverse effects can be increased when secobarbital is combined with bupivacaine.


The risk or severity of adverse effects can be increased when Clofarabine is combined with diltiazem.


The risk or severity of adverse effects can be increased when Spirapril is combined with nimesulide.


The risk or severity of adverse effects can be increased when clomipramine is combined with metaproterenol.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with tizanidine.


The risk or severity of adverse effects can be increased when methscopolamine is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when dyclonine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when milrinone is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when chloroquine is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when barnidipine is combined with clozapine.


The risk or severity of adverse effects can be increased when Rotigotine is combined with enalapril.


The risk or severity of adverse effects can be increased when MELPERONE is combined with ethotoin.


The risk or severity of adverse effects can be increased when ramipril is combined with quinapril.


The risk or severity of adverse effects can be increased when ondansetron is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Droxicam is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when secobarbital is combined with Etomidate.


The risk or severity of adverse effects can be increased when thiopental is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when apomorphine is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when apomorphine is combined with bupivacaine.


The risk or severity of adverse effects can be increased when apomorphine is combined with morphine.


The risk or severity of adverse effects can be increased when Eprosartan is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when Torasemide is combined with D-mannitol.


The risk or severity of adverse effects can be increased when Butethal is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when griseofulvin is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when benazepril is combined with penbutolol.


The risk or severity of adverse effects can be increased when isoflurane is combined with diazepam.


The risk or severity of adverse effects can be increased when ketorolac is combined with fluocinonide.


The risk or severity of adverse effects can be increased when temazepam is combined with propofol.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with Pizotifen.


The risk or severity of adverse effects can be increased when clorazepate is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when fluoxetine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with protriptyline.


The risk or severity of adverse effects can be increased when timolol is combined with D-mannitol.


The risk or severity of adverse effects can be increased when Phenelzine is combined with Arformoterol.


The risk or severity of adverse effects can be increased when oxprenolol is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when midazolam is combined with trimipramine.


The risk or severity of adverse effects can be increased when moclobemide is combined with hydromorphone.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when timolol is combined with Nebivolol.


The risk or severity of adverse effects can be increased when meperidine is combined with Halazepam.


The risk or severity of adverse effects can be increased when meperidine is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when phenobarbital is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when meperidine is combined with proparacaine.


The risk or severity of adverse effects can be increased when meperidine is combined with indapamide.


The risk or severity of adverse effects can be increased when Rotigotine is combined with benazepril.


The risk or severity of adverse effects can be increased when meperidine is combined with chlormezanone.


The risk or severity of adverse effects can be increased when apomorphine is combined with D-mannitol.


The risk or severity of adverse effects can be increased when cabergoline is combined with dexamethasone.


The risk or severity of adverse effects can be increased when meperidine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when cabergoline is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when cabergoline is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when acemetacin is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when Clofarabine is combined with captopril.


The risk or severity of adverse effects can be increased when meperidine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when Aclidinium is combined with codeine.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with reserpine.


The risk or severity of adverse effects can be increased when zopiclone is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with trimipramine.


The risk or severity of adverse effects can be increased when alprazolam is combined with enflurane.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when Lacidipine is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when diclofenac is combined with ibuprofen.


The risk or severity of adverse effects can be increased when halcinonide is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when terbinafine is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when clomipramine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when enflurane is combined with triprolidine.


The risk or severity of adverse effects can be increased when pimozide is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when alprazolam is combined with Articaine.


The risk or severity of adverse effects can be increased when methylene blue is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with felbamate.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when flutamide is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when amobarbital is combined with loratadine.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with METAXALONE.


The risk or severity of adverse effects can be increased when benzocaine is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when zaleplon is combined with diphenhydramine.


The risk or severity of adverse effects can be increased when dibucaine is combined with dyclonine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with triazolam.


The risk or severity of adverse effects can be increased when quetiapine is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when quazepam is combined with nitrazepam.


The risk or severity of adverse effects can be increased when propranolol is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when tizanidine is combined with tiagabine.


The risk or severity of adverse effects can be increased when trazodone is combined with sertraline.


The risk or severity of adverse effects can be increased when oxaprozin is combined with Propacetamol.


The risk or severity of adverse effects can be increased when clorazepate is combined with scopolamine.


The risk or severity of adverse effects can be increased when ibuprofen is combined with acemetacin.


The risk or severity of adverse effects can be increased when bupivacaine is combined with meclizine.


The risk or severity of adverse effects can be increased when atenolol is combined with Nebivolol.


The risk or severity of adverse effects can be increased when trimipramine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when PROCATEROL is combined with METHAMPHETAMINE.


The risk or severity of adverse effects can be increased when METAXALONE is combined with promethazine.


The risk or severity of adverse effects can be increased when prazosin is combined with irbesartan.


The risk or severity of adverse effects can be increased when polythiazide is combined with mecamylamine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when ketorolac is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when amobarbital is combined with Ramelteon.


The risk or severity of adverse effects can be increased when amobarbital is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with Almotriptan.


The risk or severity of adverse effects can be increased when meprobamate is combined with trimipramine.


The risk or severity of adverse effects can be increased when meprobamate is combined with procaine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with nifedipine.


The risk or severity of adverse effects can be increased when benazepril is combined with enalapril.


The risk or severity of adverse effects can be increased when benazepril is combined with diclofenac.


The risk or severity of adverse effects can be increased when tizanidine is combined with zonisamide.


The risk or severity of adverse effects can be increased when nicergoline is combined with ethanol.


The risk or severity of adverse effects can be increased when Butethal is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when clozapine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when trandolapril is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with Prasugrel.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with Tixocortol.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with epirizole.


The risk or severity of adverse effects can be increased when Azelnidipine is combined with simvastatin.


The risk or severity of adverse effects can be increased when aspirin is combined with Apixaban.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with sulpiride.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with nimodipine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with betaxolol.


The risk or severity of adverse effects can be increased when bepridil is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when thioridazine is combined with trandolapril.


The risk or severity of adverse effects can be increased when edrophonium is combined with methacholine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with ethosuximide.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when levorphanol is combined with tiapride.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with captopril.


The risk or severity of adverse effects can be increased when butamben is combined with sertraline.


The risk or severity of adverse effects can be increased when carbamazepine is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with acebutolol.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with thiopental.


The risk or severity of adverse effects can be increased when epirizole is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with propoxyphene.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with dyclonine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with perphenazine.


The risk or severity of adverse effects can be increased when epirizole is combined with amcinonide.


The risk or severity of adverse effects can be increased when efavirenz is combined with Milnacipran.


The risk or severity of adverse effects can be increased when procarbazine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when Paliperidone is combined with tetracaine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when morniflumate is combined with resveratrol.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when pergolide is combined with methimazole.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with Olsalazine.


The risk or severity of adverse effects can be increased when apomorphine is combined with dipyridamole.


The risk or severity of adverse effects can be increased when chlorpheniramine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when butabarbital is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when butabarbital is combined with bupivacaine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when butabarbital is combined with Etomidate.


The risk or severity of adverse effects can be increased when flurazepam is combined with Articaine.


The risk or severity of adverse effects can be increased when dyclonine is combined with mepivacaine.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with scopolamine.


The risk or severity of adverse effects can be increased when midazolam is combined with Fospropofol.


The risk or severity of adverse effects can be increased when perphenazine is combined with mesoridazine.


The risk or severity of adverse effects can be increased when Etidocaine is combined with clidinium.


The risk or severity of adverse effects can be increased when CICLOPIROX is combined with diltiazem.


The risk or severity of adverse effects can be increased when demeclocycline is combined with ADAPALENE.


The risk or severity of adverse effects can be increased when methylprednisolone is combined with fleroxacin.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with maprotiline.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Clofarabine is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when meprobamate is combined with HEROIN.


The risk or severity of adverse effects can be increased when Remoxipride is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when olanzapine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when indomethacin is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when olanzapine is combined with glutethimide.


The risk or severity of adverse effects can be increased when sulindac is combined with loteprednol.


The risk or severity of adverse effects can be increased when Rotigotine is combined with nimodipine.


The risk or severity of adverse effects can be increased when ondansetron is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when scopolamine is combined with citalopram.


The risk or severity of adverse effects can be increased when morphine is combined with thiamylal.


The risk or severity of adverse effects can be increased when Anidulafungin is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with meclizine.


The risk or severity of adverse effects can be increased when cilazapril is combined with nimesulide.


The risk or severity of adverse effects can be increased when scopolamine is combined with oxyphenonium.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with triamcinolone.


The risk or severity of adverse effects can be increased when triflupromazine is combined with clonidine.


The risk or severity of adverse effects can be increased when butabarbital is combined with scopolamine.


The risk or severity of adverse effects can be increased when mecamylamine is combined with hydromorphone.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when isradipine is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with Salsalate.


The risk or severity of adverse effects can be increased when paramethasone is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when oxprenolol is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when Olsalazine is combined with triamcinolone.


The risk or severity of adverse effects can be increased when gabapentin is combined with tizanidine.


The risk or severity of adverse effects can be increased when lorazepam is combined with Iloperidone.


The risk or severity of adverse effects can be increased when Eprosartan is combined with alclofenac.


The risk or severity of adverse effects can be increased when Etidocaine is combined with scopolamine.


The risk or severity of adverse effects can be increased when furosemide is combined with amikacin.


The risk or severity of adverse effects can be increased when lithium ion is combined with primidone.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with pirenzepine.


The risk or severity of adverse effects can be increased when dibucaine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when 5-Fluorocytosine is combined with cinnarizine.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when risperidone is combined with clidinium.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Lurasidone.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with propoxyphene.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when thalidomide is combined with methazolamide.


The risk or severity of adverse effects can be increased when thalidomide is combined with Eplerenone.


The risk or severity of adverse effects can be increased when ketorolac is combined with oxaprozin.


The risk or severity of adverse effects can be increased when meperidine is combined with buspirone.


The risk or severity of adverse effects can be increased when chlormezanone is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when nisoldipine is combined with MAGNESIUM HYDROXIDE.


The risk or severity of adverse effects can be increased when chloroquine is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when propofol is combined with Sacubitril.


The risk or severity of adverse effects can be increased when methyldopa is combined with acebutolol.


The risk or severity of adverse effects can be increased when diflunisal is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when docetaxel is combined with Lenvatinib.


The risk or severity of adverse effects can be increased when methyldopa is combined with captopril.


The risk or severity of adverse effects can be increased when Tolcapone is combined with propranolol.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with ifosfamide.


The risk or severity of adverse effects can be increased when Tolcapone is combined with clonidine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with meperidine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with loratadine.


The risk or severity of adverse effects can be increased when buprenorphine is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when ipratropium is combined with Normethadone.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with brimonidine.


The risk or severity of adverse effects can be increased when Ramelteon is combined with Difenoxin.


The risk or severity of adverse effects can be increased when butorphanol is combined with ethosuximide.


The risk or severity of adverse effects can be increased when halcinonide is combined with norfloxacin.


The risk or severity of adverse effects can be increased when buprenorphine is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when butorphanol is combined with thiopental.


The risk or severity of adverse effects can be increased when halcinonide is combined with Echothiophate.


The risk or severity of adverse effects can be increased when METYROSINE is combined with periciazine.


The risk or severity of adverse effects can be increased when ethotoin is combined with Desloratadine.


The risk or severity of adverse effects can be increased when Treprostinil is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when Telmisartan is combined with nadolol.


The risk or severity of adverse effects can be increased when thiopental is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when tenoxicam is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when nortriptyline is combined with Cariprazine.


The risk or severity of adverse effects can be increased when Glycopyrronium is combined with oxycodone.


The risk or severity of adverse effects can be increased when mafenide is combined with mecamylamine.


The risk or severity of adverse effects can be increased when sulpiride is combined with digitoxin.


The risk or severity of adverse effects can be increased when oxiconazole is combined with fluvastatin.


The risk or severity of adverse effects can be increased when Carbetocin is combined with propranolol.


The risk or severity of adverse effects can be increased when Carbetocin is combined with clonidine.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with Mirabegron.


The risk or severity of adverse effects can be increased when Nepafenac is combined with triamcinolone.


The risk or severity of adverse effects can be increased when Levetiracetam is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when oxazepam is combined with amisulpride.


The risk or severity of adverse effects can be increased when Tapentadol is combined with Torasemide.


The risk or severity of adverse effects can be increased when tropicamide is combined with biperiden.


The risk or severity of adverse effects can be increased when lorazepam is combined with alprazolam.


The risk or severity of adverse effects can be increased when oxazepam is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with formestane.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with rasagiline.


The risk or severity of adverse effects can be increased when oxaprozin is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with fenoprofen.


The risk or severity of adverse effects can be increased when testosterone propionate is combined with selegiline.


The risk or severity of adverse effects can be increased when nefazodone is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with chloroquine.


The risk or severity of adverse effects can be increased when diflunisal is combined with rosiglitazone.


The risk or severity of adverse effects can be increased when tenoxicam is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with sulindac.


The risk or severity of adverse effects can be increased when Tianeptine is combined with phenylpropanolamine.


The risk or severity of adverse effects can be increased when buspirone is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when perphenazine is combined with olanzapine.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with amitriptyline.


The risk or severity of adverse effects can be increased when butabarbital is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Apremilast is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when Lofexidine is combined with Nabilone.


The risk or severity of adverse effects can be increased when docetaxel is combined with testolactone.


The risk or severity of adverse effects can be increased when salicylic acid is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when cabergoline is combined with fluoxetine.


The risk or severity of adverse effects can be increased when isoflurane is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when lorazepam is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when lorazepam is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when lorazepam is combined with Escitalopram.


The risk or severity of adverse effects can be increased when methylergonovine is combined with clotiazepam.


The risk or severity of adverse effects can be increased when levodopa is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when zonisamide is combined with flunarizine.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with hydromorphone.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with estrone.


The risk or severity of adverse effects can be increased when lorazepam is combined with sevoflurane.


The risk or severity of adverse effects can be increased when antipyrine is combined with flumethasone.


The risk or severity of adverse effects can be increased when selegiline is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when Articaine is combined with butalbital.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when methocarbamol is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Carbetocin is combined with nimodipine.


The risk or severity of adverse effects can be increased when carbamazepine is combined with zotepine.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with paroxetine.


The risk or severity of adverse effects can be increased when efavirenz is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when carbamazepine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when efavirenz is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Lurasidone is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Tolcapone.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with apraclonidine.


The risk or severity of adverse effects can be increased when Limaprost is combined with Ticagrelor.


The risk or severity of adverse effects can be increased when enflurane is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when Limaprost is combined with Triflusal.


The risk or severity of adverse effects can be increased when methylergonovine is combined with nilvadipine.


The risk or severity of adverse effects can be increased when proparacaine is combined with efavirenz.


The risk or severity of adverse effects can be increased when enflurane is combined with glutethimide.


The risk or severity of adverse effects can be increased when Nelarabine is combined with leflunomide.


The risk or severity of adverse effects can be increased when Asenapine is combined with tiapride.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when morphine is combined with carvedilol.


The risk or severity of adverse effects can be increased when Articaine is combined with primidone.


The risk or severity of adverse effects can be increased when ISOSORBIDE DINITRATE is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when secobarbital is combined with zotepine.


The risk or severity of adverse effects can be increased when Tofacitinib is combined with clozapine.


The risk or severity of adverse effects can be increased when perphenazine is combined with promethazine.


The risk or severity of adverse effects can be increased when perphenazine is combined with clonazepam.


The risk or severity of adverse effects can be increased when Estrone sulfate is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when Arotinolol is combined with nadolol.


The risk or severity of adverse effects can be increased when tacrolimus is combined with Fludarabine.


The risk or severity of adverse effects can be increased when perphenazine is combined with Melatonin.


The risk or severity of adverse effects can be increased when tacrolimus is combined with atorvastatin.


The risk or severity of adverse effects can be increased when nisoldipine is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with quetiapine.


The risk or severity of adverse effects can be increased when nisoldipine is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when tiapride is combined with Olopatadine.


The risk or severity of adverse effects can be increased when dexamethasone is combined with cinoxacin.


The risk or severity of adverse effects can be increased when Remoxipride is combined with fludiazepam.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when pergolide is combined with Levalbuterol.


The risk or severity of adverse effects can be increased when olanzapine is combined with flunarizine.


The risk or severity of adverse effects can be increased when buspirone is combined with Asenapine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with sevoflurane.


The risk or severity of adverse effects can be increased when isradipine is combined with captopril.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with desipramine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with Riociguat.


The risk or severity of adverse effects can be increased when amifostine is combined with apomorphine.


The risk or severity of adverse effects can be increased when minocycline is combined with tretinoin.


The risk or severity of adverse effects can be increased when flurazepam is combined with dibucaine.


The risk or severity of adverse effects can be increased when Voriconazole is combined with cinnarizine.


The risk or severity of adverse effects can be increased when difluprednate is combined with norfloxacin.


The risk or severity of adverse effects can be increased when budesonide is combined with Demecarium.


The risk or severity of adverse effects can be increased when difluprednate is combined with Echothiophate.


The risk or severity of adverse effects can be increased when triazolam is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when Spirapril is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when trandolapril is combined with nabumetone.


The risk or severity of adverse effects can be increased when methysergide is combined with Posaconazole.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with suprofen.


The risk or severity of adverse effects can be increased when benztropine is combined with codeine.


The risk or severity of adverse effects can be increased when HEROIN is combined with Canrenoic acid.


The risk or severity of adverse effects can be increased when HEROIN is combined with brotizolam.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with ethotoin.


The risk or severity of adverse effects can be increased when butorphanol is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when rasagiline is combined with tretinoin.


The risk or severity of adverse effects can be increased when Clofarabine is combined with Conivaptan.


The risk or severity of adverse effects can be increased when hydrochlorothiazide is combined with Bretylium.


The risk or severity of adverse effects can be increased when Clofarabine is combined with Eprosartan.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with risperidone.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with hydralazine.


The risk or severity of adverse effects can be increased when Canagliflozin is combined with Riociguat.


The risk or severity of adverse effects can be increased when Caspofungin is combined with Pinaverium.


The risk or severity of adverse effects can be increased when butamben is combined with clidinium.


The risk or severity of adverse effects can be increased when imipramine is combined with felbamate.


The risk or severity of adverse effects can be increased when paroxetine is combined with trimipramine.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when ibuprofen is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when trimipramine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when lithium ion is combined with Etidocaine.


The risk or severity of adverse effects can be increased when Bortezomib is combined with Flibanserin.


The risk or severity of adverse effects can be increased when propantheline is combined with hydromorphone.


The risk or severity of adverse effects can be increased when Difenoxin is combined with Retigabine.


The risk or severity of adverse effects can be increased when salicylamide is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when promazine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when promazine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when atenolol is combined with losartan.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when isoflurane is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when Efonidipine is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when polythiazide is combined with acetyldigitoxin.


The risk or severity of adverse effects can be increased when cetirizine is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when Sacubitril is combined with Droxicam.


The risk or severity of adverse effects can be increased when Sacubitril is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when Tolcapone is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when Sacubitril is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when morphine is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with promethazine.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with clonazepam.


The risk or severity of adverse effects can be increased when thalidomide is combined with hydralazine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when ketamine is combined with zotepine.


The risk or severity of adverse effects can be increased when HYDROCODONE is combined with potassium ion.


The risk or severity of adverse effects can be increased when amifostine is combined with thalidomide.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with carprofen.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with benzphetamine.


The risk or severity of adverse effects can be increased when Anidulafungin is combined with isradipine.


The risk or severity of adverse effects can be increased when pramipexole is combined with betaxolol.


The risk or severity of adverse effects can be increased when tiapride is combined with doxepin.


The risk or severity of adverse effects can be increased when Dimethyl fumarate is combined with leflunomide.


The risk or severity of adverse effects can be increased when triprolidine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when triprolidine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Nabilone is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when Nabilone is combined with cilazapril.


The risk or severity of adverse effects can be increased when citalopram is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when Olsalazine is combined with dexamethasone.


The risk or severity of adverse effects can be increased when haloperidol is combined with Articaine.


The risk or severity of adverse effects can be increased when glutethimide is combined with dantrolene.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with Propacetamol.


The risk or severity of adverse effects can be increased when Almotriptan is combined with Asenapine.


The risk or severity of adverse effects can be increased when Melatonin is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when thiothixene is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when LEVOBUNOLOL is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with nortriptyline.


The risk or severity of adverse effects can be increased when thiothixene is combined with Remoxipride.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with amoxapine.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with tetracaine.


The risk or severity of adverse effects can be increased when clonidine is combined with tizanidine.


The risk or severity of adverse effects can be increased when clonidine is combined with furosemide.


The risk or severity of adverse effects can be increased when clonidine is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when Talniflumate is combined with ZILEUTON.


The risk or severity of adverse effects can be increased when Butethal is combined with trimipramine.


The risk or severity of adverse effects can be increased when Talniflumate is combined with etodolac.


The risk or severity of adverse effects can be increased when Olmesartan is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when imipramine is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when butorphanol is combined with zonisamide.


The risk or severity of adverse effects can be increased when paroxetine is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when Paliperidone is combined with METAXALONE.


The risk or severity of adverse effects can be increased when Halobetasol is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when citalopram is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when enflurane is combined with procaine.


The risk or severity of adverse effects can be increased when butorphanol is combined with tiagabine.


The risk or severity of adverse effects can be increased when butorphanol is combined with cocaine.


The risk or severity of adverse effects can be increased when butorphanol is combined with ondansetron.


The risk or severity of adverse effects can be increased when vigabatrin is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with acemetacin.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when vigabatrin is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when dyclonine is combined with zotepine.


The risk or severity of adverse effects can be increased when dyclonine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when Etomidate is combined with fexofenadine.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when glutethimide is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with butamben.


The risk or severity of adverse effects can be increased when pargyline is combined with bupropion.


The risk or severity of adverse effects can be increased when oxycodone is combined with nortriptyline.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with buprenorphine.


The risk or severity of adverse effects can be increased when acetazolamide is combined with SODIUM BICARBONATE.


The risk or severity of adverse effects can be increased when acemetacin is combined with fluocinonide.


The risk or severity of adverse effects can be increased when methscopolamine is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when resveratrol is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when dibucaine is combined with nefazodone.


The risk or severity of adverse effects can be increased when spironolactone is combined with Clevidipine.


The risk or severity of adverse effects can be increased when enalapril is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when enalapril is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with efavirenz.


The risk or severity of adverse effects can be increased when cilnidipine is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when flurandrenolide is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when lorazepam is combined with scopolamine.


The risk or severity of adverse effects can be increased when cilnidipine is combined with methazolamide.


The risk or severity of adverse effects can be increased when cilnidipine is combined with Eplerenone.


The risk or severity of adverse effects can be increased when aspirin is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when Olmesartan is combined with quinapril.


The risk or severity of adverse effects can be increased when flurandrenolide is combined with malathion.


The risk or severity of adverse effects can be increased when Olmesartan is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when promazine is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when Nabilone is combined with nitric oxide.


The risk or severity of adverse effects can be increased when Nabilone is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Pazopanib.


The risk or severity of adverse effects can be increased when medrysone is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when ropinirole is combined with Olmesartan.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with mesoridazine.


The risk or severity of adverse effects can be increased when Isoconazole is combined with nitrendipine.